DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 99 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,325,000 | -46.0% | 65,742 | 0.0% | 0.18% | -46.4% |
| Q2 2021 | $2,453,000 | +45.9% | 65,742 | 0.0% | 0.34% | +35.2% |
| Q1 2021 | $1,681,000 | +16.1% | 65,742 | 0.0% | 0.25% | +11.6% |
| Q4 2020 | $1,448,000 | +37.6% | 65,742 | +12.5% | 0.22% | +37.4% |
| Q3 2020 | $1,052,000 | -12.1% | 58,457 | +24.0% | 0.16% | -0.6% |
| Q2 2020 | $1,197,000 | +38.2% | 47,143 | 0.0% | 0.16% | +18.0% |
| Q1 2020 | $866,000 | -16.7% | 47,143 | 0.0% | 0.14% | +23.0% |
| Q4 2019 | $1,039,000 | +283.4% | 47,143 | +150.0% | 0.11% | +253.1% |
| Q3 2019 | $271,000 | -8.8% | 18,857 | 0.0% | 0.03% | -15.8% |
| Q2 2019 | $297,000 | +7.6% | 18,857 | 0.0% | 0.04% | +8.6% |
| Q1 2019 | $276,000 | +19.5% | 18,857 | 0.0% | 0.04% | 0.0% |
| Q4 2018 | $231,000 | -19.8% | 18,857 | 0.0% | 0.04% | -14.6% |
| Q3 2018 | $288,000 | +24.7% | 18,857 | 0.0% | 0.04% | +17.1% |
| Q2 2018 | $231,000 | +28.3% | 18,857 | 0.0% | 0.04% | +20.7% |
| Q1 2018 | $180,000 | – | 18,857 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $89,888,000 | 13.40% |
| EcoR1 Capital, LLC | 3,627,597 | $79,916,000 | 7.20% |
| Aquilo Capital Management, LLC | 614,436 | $13,536,000 | 5.08% |
| RTW INVESTMENTS, LP | 5,874,229 | $129,409,000 | 4.88% |
| BRIDGER MANAGEMENT, LLC | 1,981,633 | $43,655,000 | 3.15% |
| ACUTA CAPITAL PARTNERS, LLC | 387,500 | $8,537,000 | 2.11% |
| Integral Health Asset Management, LLC | 200,000 | $4,406,000 | 1.72% |
| Burrage Capital Management LLC | 104,047 | $2,292,000 | 1.54% |
| Parkman Healthcare Partners LLC | 240,000 | $5,287,000 | 1.53% |
| EAM Global Investors LLC | 122,237 | $2,693,000 | 1.08% |